其它产品项目整合

项目整合的本质是一项集合成方法学、反应工程学与过程分析技术于一体的系统工程。其核心逻辑可以概括为以下几点：源头优选：利用如N-硝胺化学等底层方法学突破，从分子层面颠覆传统高成本、高污染路线。过程强化：依托连续流技术，攻克有机金属试剂应用、光化学反应放大等“不可能”任务，实现高危工艺的本质安全。系统集成：整合“反应-淬灭-分离”全流程，利用微流控与在线分析技术，消除批次间的差异，实现药品制造的连续化与智能化。当前，中间体工艺研发正在经历从“经验驱动”向“数据驱动”的转变。AI辅助路线设计、自动化高通量筛选与连续制造平台的结合，将使得“分子结构与最优工艺路径”之间的映射关系逐渐清晰。未来的竞争优势，将属于那些能够将底层化学创新与先进工程技术进行无缝整合的研发体系。
备注: 根据相关法律法规, 本站点不显示有法律约束管制的产品, 如有遗漏, 请自行鉴别,或提交我们及时更新撤除.
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

其它产品项目整合

Toxiferine I CAS Registry Number: 6888-23-9

Additional Names: C-Toxiferine I
Literature References: Naturally occurring neuromuscular blocker. From calabash curare: Schmid, Karrer, Helv. Chim. Acta 30, 1162 (1947); from Strychnos toxifera Schomb., Loganiaceae: Wieland et al., Ann. 547, 156 (1941); King, J. Chem. Soc. 1949, 3263. Identity with toxiferine V and toxiferine XI: Battersby et al., ibid. 1960, 1848. Structure: Arnold et al., Helv. Chim. Acta 44, 620 (1961). Synthesis: Berlage et al., ibid. 42, 394 (1959); Grdinic et al., J. Am. Chem. Soc. 86, 3357 (1964). Pharmacokinetics: P. G. Waser, J. Reller, Agents Actions 2, 170 (1972). 13C-NMR study: E. Wenkert et al., J. Org. Chem. 43, 1099 (1978).

Citicoline CAS Registry Number: 987-78-0 胞磷胆碱

CAS Name: Cytidine 5'-(trihydrogen diphosphate) P'-[2-(trimethylammonio)ethyl] ester inner salt
Additional Names: choline cytidine 5'-pyrophosphate (ester); cytidine diphosphate choline ester; ...
Literature References: Naturally occurring nucleotide; intermediate in the major pathway of lecithin biosynthesis. Identification: E. P. Kennedy, S. B. Weiss, J. Am. Chem. Soc. 77, 250 (1955). Crystallization from yeast extract: I. Lieberman et al., Science 124, 81 (1956). Synthesis: E. P. Kennedy, J. Biol. Chem. 222, 185 (1956); K. Kikugawa et al., Chem. Pharm. Bull. 19, 1011, 2466 (1971). Molecular structure: M. A. Viswamitra et al., Nature 258, 497 (1975). Series of articles on pharmacology and toxicology: Arzneim.-Forsch. 33, 1009-1080 (1983). Acute toxicity: T. Grau et al., ibid. 1033. Clinical trial in ischemic stroke: W. M. Clark et al., Neurology 49, 671 (1997). Review of biosynthesis, metabolism, pharmacology: G. B. Weiss, Life Sci. 56, 637-660 (1995); and clinical experience: J. J. Secades, G. Frontera, Methods Find. Exp. Clin. Pharmacol. 17, Suppl. B, 1-54 (1995).

S-Methylmethionine CAS Registry Number: 4727-40-6 S-甲基-L-蛋氨酸

CAS Name: [(3S)-3-Amino-3-carboxypropyl]dimethyl sulfonium inner salt
Additional Names: S-methyl-L-methionine; MeMet; vitamin U
Percent Composition: C 44.15%, H 8.03%, N 8.58%, O 19.60%, S 1...
Literature References: Naturally occurring sulfonium compound found in a large number of plants. Identification of antiulcer vitamin in cabbage leaves: G. Cheney, Calif. Med. 77, 248 (1952). Isoln from cabbage juice: R. A. McRorie et al., J. Am. Chem. Soc. 76, 115 (1954). Activity: V. Z. Szabo, G. Vargha, Arzneim.-Forsch. 10, 23 (1960). Determn in plant tissue: P. K. Macnicol, Anal. Biochem. 158, 93 (1986). Review of biosynthesis and physiological role in plants: J. Giovanelli et al., "Sulfur Amino Acids in Plants " in The Biochemistry of Plants 5, B. J. Miflin, Ed. (Academic Press, New York, 1980) pp 453-505.

Betulinic Acid CAS Registry Number: 472-15-1 白桦脂酸

CAS Name: (3b)-3-Hydroxylup-20(29)-en-28-oic acid
Additional Names: betulic acidPercent Composition: C 78.90%, H 10.59%, O 10.51%
Literature References: Naturally occurring triterpene found in many plant sources, notably the bark of white birch trees, Betula alba L. Betulaceae. Melanoma-specific cytotoxic agent. Isoln: L. Ruzicka et al., Helv. Chim. Acta 21, 1706 (1938); and characterization: A. Robertson et al., J. Chem. Soc. 1939, 1267. Synthesis from betulin, q.v.: D. S. H. Kim et al., Synth. Commun. 27, 1607 (1997). Isoln and crystal structure of benzyl ester: G. Bringmann et al., Planta Med. 63, 255 (1997). Inhibition of HIV replication: T. Fujioka et al., J. Nat. Prod. 57, 243 (1994). Induction of apoptosis in human melanoma cells: E. Pisha et al., Nat. Med. 1, 1046 (1995). Mechanism of action study: S. Fulda et al., Cancer Res. 57, 4956 (1997). Pharmacokinetics in mice: G. O. Udeani et al., Biopharm. Drug Dispos. 20, 379 (1999). Tumor cell-specific cytotoxicity: V. Zuco et al., Cancer Lett. 175, 17 (2002). LC/MS determn in plasma: X. Cheng et al., Rapid Commun. Mass Spectrom. 17, 2089 (2003). Review of natural distribution: G. Pavanasasivam, M. U. S. Sultanbawa, Phytochemistry 13, 2002-2006 (1974); of anticancer activity: D. A. Eiznhamer, Z.-Q. Xu, IDrugs 7, 359-373 (2004); of chemistry, biology and therapeutic potential: R. H. Cichewicz, S. A. Kouzi, Med. Res. Rev. 24, 90-114 (2004); of biological properties: P. Yogeeswari, D. Sriram, Curr. Med. Chem. 12, 657-666 (2005).

Neovitamin A CAS Registry Number: 2052-63-3 13-顺式视黄醇

CAS Name: 13-cis-Retinol
Additional Names: 2-cis-vitamin A
Percent Composition: C 83.86%, H 10.56%, O 5.59%
Literature References: Naturally occurring, bioactive isomer of vitamin A, q.v. The 13-cis- and all-trans-forms come to equilibrium in solution with ~33% as 13-cis. Isoln from shark liver oil: C. D. Robeson, J. G. Baxter, J. Am. Chem. Soc. 69, 136 (1947). Synthesis: M. Matsui et al., J. Vitaminol. 4, 178 (1958). Stereoselective synthesis: J. Otera et al., Chem. Lett. 1985, 1883. HPLC determn in food samples: E. Brinkmann et al., J. Chromatogr. A 693, 271 (1995). Review of vitamin A compounds: W. Friedrich in Vitamins (Walter de Gruyter, Berlin, 1988) pp 63-140.

Pyrrolysine CAS Registry Number: 448235-52-7

CAS Name: N6-[(3R)-1,5-Didehydro-3-methyl-D-prolyl]-L-lysine
Additional Names: L-pyrrolysine
Percent Composition: C 56.45%, H 8.29%, N 16.46%, O 18.80%
Literature References: Naturally occurring, genetically encoded amino acid found in certain methanogenic Archaea; originally described as L-lysine e-amide linked to (4R,5R)-4-substituted-1-pyrroline-5-carboxylate. Identification of pyrrolysine-specific tRNA in Methanosarcina barkeri: G. Srinivasan et al., Science 296, 1459 (2002). Identification as UAG-encoded residue in monomethylamine methyltransferase: B. Hao et al., ibid. 1462. Identification of C4-substituent as a methyl group, synthesis and properties: idem et al., Chem Biol. 11, 1317 (2004). MS analysis: J. A. Soares et al., J. Biol. Chem. 280, 36962 (2005). Reviews: C. Fenske et al., Angew. Chem. Int. Ed. 42, 606-610 (2003); J. A. Krzycki, Curr. Opin. Microbiol. 8, 706-712 (2005).

Asperlicin CAS Registry Number: 93413-04-8

CAS Name: (7S)-6,7-Dihydro-7-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione
Percent Com...
Literature References: Naturally occurring, nonpeptide cholecystokinin (CCK) antagonist. Produced by several strains of Aspergillus alliaceus along with minor related compounds known as asperlicin B, C, D and E. Isoln from fermentation cultures of A. alliaceus Thom and Church, ATCC 20655 and ATCC 20656: R. L. Monaghan et al., EP 116150; eidem, US 4530790 (1984, 1985 both to Merck Co.). Fermentation, isoln and bioactivity: M. A. Goetz et al., J. Antibiot. 38, 1633 (1985); of asperlicins B, C, D and E: eidem, ibid. 41, 875 (1988). Structure elucidation: J. M. Liesch et al., ibid. 38, 1638 (1985); of asperlicins B, C, D and E: eidem, ibid. 41, 878 (1988). Biosynthetic study: D. R. Houck et al., ibid. 882. Total synthesis of asperlicins C and E: M. G. Bock et al., J. Org. Chem. 52, 1644 (1987). Pharmacology of asperlicin: R. S. L. Chang et al., Science 230, 177 (1985). Effect on pancreatic enzyme secretion in vitro: K. A. Zucker et al., Surgery 102, 163 (1987). Effect in exptl pancreatitis in rats: J. R. Wisner, Jr., I. G. Renner, Pancreas 3, 174 (1988).

VX CAS Registry Number: 50782-69-9 O-乙基-S-[2-(二异丙氨基)乙基]甲基硫代磷酸酯

CAS Name: Methylphosphonothioic acid S-[2-[bis(1-methylethyl)amino]ethyl] O-ethyl ester
Additional Names: O-ethyl S-[2-(diisopropylamino)ethyl]methylphosphonothioate; Tx 60
Percent Compositi...
Literature References: Nerve gas. Prepn: R. V. Ley, G. L. Sainsbury, GB 1346409; A. W. Wardrop, C. Stratford, GB 1346410 (both 1974 to U.K. Sec. of State for Defence), C.A. 81, 4068y, 4069z (1974); S. R. Eckhaus et al., US 3911059 (1975 to U.S.A. Sec. for Army). Activity studies in humans: F. R. Sidell, W. A. Groff, Toxicol. Appl. Pharmacol. 27, 241 (1974); F. N. Craig et al., J. Invest. Dermatol. 68, 357 (1977). Toxicity study: J. J. Gordon, L. Leadbeater, Toxicol. Appl. Pharmacol. 40, 109 (1977).

Tabun CAS Registry Number: 77-81-6 二甲胺氰磷酸乙酯

CAS Name: Dimethylphosphoramidocyanidic acid, ethyl ester
Additional Names: ethyl N-dimethylphosphoramidocyanidate; dimethylamidoethoxyphosphoryl cyanide; GA
Percent Composition: C 37.04%, H...
Literature References: Nerve gas; potent cholinesterase inhibitor similar in structure and activity to sarin and soman, q.q.v. Prepd from dimethylamidophosphoryl dichloride and sodium cyanide in the presence of ethanol: Holmstedt, Acta Physiol. Scand. 25, Suppl. 90, 26 (1951). Synthesis of dimethylamidophosphoryl dichloride: Michaelis, Ann. 326, 129 (1903). Alternate synthetic route: B. C. Saunders, Some Aspects of the Chemistry and Toxic Action of Organic Compounds Containing Phosphorus and Fluorine (Cambridge, 1957) p 91. Toxicity study: B. Holmstedt, Pharmacol. Rev. 11, 567 (1959). Brief review: Schrader, Die Entwicklung neuer insektizider Phosphorsäure-Ester (Verlag Chemie, Weinheim, 1963) p 3; B. L. Harris in Kirk-Othmer Encyclopedia of Chemical Technology vol. 5 (Wiley-Interscience, New York, 4th ed., 1993) pp 795-816.

Soman CAS Registry Number: 96-64-0 甲基氟膦酸 1,2,2-三甲基丙基酯

CAS Name: Methylphosphonofluoridic acid 1,2,2-trimethylpropyl ester
Additional Names: pinacoloxymethylphosphoryl fluoride; pinacolyl methylphosphonofluoridate; GD
Percent Composition: C 46.1...
Literature References: Nerve gas; potent cholinesterase inhibitor similar in structure and activity to sarin and tabun, q.q.v. Prepn: Holmstedt, Acta Physiol. Scand. 25, suppl. 90, p 106 (1951); Protar 16, 131 (1950); G. Schrader, Die Entwicklung neuer Insektizide auf Grundlage organischer Fluor- und Phosphor-Verbindungen [Monographie Nr. 62 zu Angewandte Chemie und Chemie-Ingenieur-Technik (Verlag Chemie 1951)]; B. C. Saunders, Some Aspects of the Chemistry and Toxic Action of Organic Compounds Containing Phosphorus and Fluorine (Cambridge, 1957) p 94. Toxicity study: Loomis, Salafsky, Toxicol. Appl. Pharmacol. 5, 685 (1963). Brief description: B. L. Harris in Kirk-Othmer Encyclopedia of Chemical Technology vol. 5 (Wiley-Interscience, New York, 4th ed., 1993) pp 795-816.